Emily E. Bosco
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cell Biology top 5%
- Microtubule and mitosis dynamics
Papers in
-
- DNA Repair Mechanisms 4
- Cancer therapeutics and mechanisms 3
- TGF-β signaling in diseases 2
- Retinoids in leukemia and cellular processes 2
- Glycosylation and Glycoproteins Research 2
- Oncology 13
- Cancer-related Molecular Pathways 8
- CAR-T cell therapy research 2
- Co-authors
- Yi Zheng (5 shared papers)James C. Mulloy (2 shared papers)Erik S. Knudsen (7 shared papers)Huan Xu (2 shared papers)Bruce J. Aronow (2 shared papers)Scott W. Lowe (1 shared paper)Karen E. Knudsen (1 shared paper)Ying Wang (1 shared paper)
- Journals
- Cancer Research (5 papers)Oncogene (3 papers)Nucleic Acids Research (2 papers)Cancer Biology & Therapy (1 paper)Cell Cycle (1 paper)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Emily E. Bosco
19 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Oncology 463
- Cell Biology 229
- Cancer Research 207
- Molecular Biology 654
- Ophthalmology 74
Countries citing papers authored by Emily E. Bosco
This map shows the geographic impact of Emily E. Bosco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Bosco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Bosco more than expected).
Fields of papers citing papers by Emily E. Bosco
This network shows the impact of papers produced by Emily E. Bosco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Bosco. The network helps show where Emily E. Bosco may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily E. Bosco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 285 | |
| 2 | 2006 | 150 | |
| 3 | 2008 | 126 | |
| 4 | 2007 | 87 | |
| 5 | 2004 | 80 | |
| 6 | 2005 | 77 | |
| 7 | 2007 | 66 | |
| 8 | 2012 | 49 | |
| 9 | 2010 | 48 | |
| 10 | 2016 | 31 | |
| 11 | 2010 | 22 | |
| 12 | 2005 | 18 | |
| 13 | 2004 | 7 | |
| 14 | Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value. | 1993 | 7 |
| 15 | 2006 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2015 | 2 | |
| 18 | Visions and Reflections (Minireview) Rac1 GTPase: A "Rac" of All Trades | 2009 | 1 |
| 19 | 2023 | 1 | |
| 20 | 2025 | 0 |
About Emily E. Bosco
Emily E. Bosco is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Neurology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (4 papers), Cancer therapeutics and mechanisms (3 papers), TGF-β signaling in diseases (2 papers), Galectins and Cancer Biology (2 papers), CAR-T cell therapy research (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (463 citations), Cell Biology (229 citations), Cancer Research (207 citations), Molecular Biology (654 citations) and Ophthalmology (74 citations). Emily E. Bosco has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Yi Zheng, James C. Mulloy, Erik S. Knudsen, Huan Xu, Bruce J. Aronow, Scott W. Lowe, Karen E. Knudsen, Ying Wang, Jack T. Zilfou and Christopher N. Mayhew. Their work appears in journals such as Cancer Research, Oncogene, Nucleic Acids Research, Cancer Biology & Therapy and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.